Literature DB >> 17395470

Differential receptor binding characteristics of consecutive phenylalanines in micro-opioid specific peptide ligand endomorphin-2.

Takeshi Honda1, Naoto Shirasu, Kaname Isozaki, Michiaki Kawano, Daiki Shigehiro, Yoshiro Chuman, Tsugumi Fujita, Takeru Nose, Yasuyuki Shimohigashi.   

Abstract

Endogenous opioid peptides consist of a conserved amino acid residue of Phe(3) and Phe(4), although their binding modes for opioid receptors have not been elucidated in detail. Endomorphin-2, which is highly selective and specific for the mu opioid receptor, possesses two Phe residues at the consecutive positions 3 and 4. In order to clarify the role of Phe(3) and Phe(4) in binding to the mu receptor, we synthesized a series of analogs in which Phe(3) and Phe(4) were replaced by various amino acids. It was found that the aromaticity of the Phe-beta-phenyl groups of Phe(3) and Phe(4) is a principal determinant of how strongly it binds to the receptor, although better molecular hydrophobicity reinforces the activity. The receptor binding subsites of Phe(3) and Phe(4) of endomorphin-2 were found to exhibit different structural requirements. The results suggest that [Trp(3)]endomorphin-2 (native endomorphin-1) and endomorphin-2 bind to different receptor subclasses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17395470     DOI: 10.1016/j.bmc.2007.03.009

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) residues.

Authors:  Domenica Torino; Adriano Mollica; Francesco Pinnen; Federica Feliciani; Gino Lucente; Giancarlo Fabrizi; Gustavo Portalone; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

2.  Synthesis of mixed opioid affinity cyclic endomorphin-2 analogues with fluorinated phenylalanines.

Authors:  Justyna Piekielna; Renata Perlikowska; Jean Claude do-Rego; Jean-Luc do-Rego; Maria Camilla Cerlesi; Girolamo Calo; Alicja Kluczyk; Krzysztof Łapiński; Csaba Tömböly; Anna Janecka
Journal:  ACS Med Chem Lett       Date:  2015-04-03       Impact factor: 4.345

3.  Four-component pharmacophore model for endomorphins toward μ opioid receptor subtypes.

Authors:  Yng-Ching Wu; Tim Jaglinski; Jin-Yuan Hsieh; Jia-Jyun Chiu; Tzen-Yuh Chiang; Chi-Chuan Hwang
Journal:  J Mol Model       Date:  2011-05-27       Impact factor: 1.810

Review 4.  Food-Derived Opioid Peptides in Human Health: A Review.

Authors:  Akanksha Tyagi; Eric Banan-Mwine Daliri; Fred Kwami Ofosu; Su-Jung Yeon; Deog-Hwan Oh
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

Review 5.  Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery.

Authors:  Yeon Sun Lee
Journal:  Biomolecules       Date:  2022-09-05

6.  An Engineered Endomorphin-2 Gene for Morphine Withdrawal Syndrome.

Authors:  Fei-Xiang Wu; Yan He; Hui-Ting Di; Yu-Ming Sun; Rui-Rui Pan; Wei-Feng Yu; Renyu Liu
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.